Modified diatom-based ocular suspension for sustained diclofenac sodium delivery: a novel drug carrier approach.

IF 2.8 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Ramin Ghasemi Shayan, Dorsa Jalaei, Faramarz Dobakhti
{"title":"Modified diatom-based ocular suspension for sustained diclofenac sodium delivery: a novel drug carrier approach.","authors":"Ramin Ghasemi Shayan, Dorsa Jalaei, Faramarz Dobakhti","doi":"10.1186/s40360-025-00917-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Ophthalmic drugs typically last only around 15 minutes due to rapid elimination from tear flow, with only about 2% absorption, while the rest may enter the nasal mucosa, potentially causing systemic side effects. Diatoms, with properties like unique structure, abundance, low cost, heat resistance, non-toxicity, and easy access, present a promising solution for sustained drug delivery. This study aimed to prepare and evaluate an ocular suspension of diclofenac sodium loaded onto modified diatoms.</p><p><strong>Methods: </strong>Diatoms were modified with aluminum sulfate solution, followed by loading of diclofenac sodium. Characteristics of diatoms before and after modification-particle size, surface charge, and drug loading-were analyzed using electron microscopy, FTIR (Fourier Transform Infrared Spectroscopy), XRD (X-ray Diffraction), and elemental mapping. BET (Brunauer-Emmett-Teller (Surface Area Analysis) testing provided adsorption data, while DSC (Differential Scanning Calorimetry) assessed thermal properties. An in vitro release study using a dialysis bag in artificial tear fluid examined drug release over 8 hours. Drug content was determined by spectrophotometry, and cytotoxicity on MDA-MB-231 and HEP-G2 cell lines was evaluated at different diatom concentrations.</p><p><strong>Results: </strong>SEM (Scanning Electron Microscopy) imaging showed no topographic changes post-modification. BET and XRD analyses confirmed drug loading and structural stability, while FTIR indicated involvement of carboxylate groups. TGA and DSC showed stable thermal properties. Elemental mapping confirmed increased surface elements and high drug loading. Modified diatoms showed sustained drug release and no significant cytotoxicity differences.</p><p><strong>Conclusion: </strong>Modified diatoms demonstrated higher drug loading and sustained release, indicating their potential for safe and effective ocular drug delivery. Further studies are recommended to confirm these findings.</p>","PeriodicalId":9023,"journal":{"name":"BMC Pharmacology & Toxicology","volume":"26 1","pages":"77"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11983991/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40360-025-00917-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Ophthalmic drugs typically last only around 15 minutes due to rapid elimination from tear flow, with only about 2% absorption, while the rest may enter the nasal mucosa, potentially causing systemic side effects. Diatoms, with properties like unique structure, abundance, low cost, heat resistance, non-toxicity, and easy access, present a promising solution for sustained drug delivery. This study aimed to prepare and evaluate an ocular suspension of diclofenac sodium loaded onto modified diatoms.

Methods: Diatoms were modified with aluminum sulfate solution, followed by loading of diclofenac sodium. Characteristics of diatoms before and after modification-particle size, surface charge, and drug loading-were analyzed using electron microscopy, FTIR (Fourier Transform Infrared Spectroscopy), XRD (X-ray Diffraction), and elemental mapping. BET (Brunauer-Emmett-Teller (Surface Area Analysis) testing provided adsorption data, while DSC (Differential Scanning Calorimetry) assessed thermal properties. An in vitro release study using a dialysis bag in artificial tear fluid examined drug release over 8 hours. Drug content was determined by spectrophotometry, and cytotoxicity on MDA-MB-231 and HEP-G2 cell lines was evaluated at different diatom concentrations.

Results: SEM (Scanning Electron Microscopy) imaging showed no topographic changes post-modification. BET and XRD analyses confirmed drug loading and structural stability, while FTIR indicated involvement of carboxylate groups. TGA and DSC showed stable thermal properties. Elemental mapping confirmed increased surface elements and high drug loading. Modified diatoms showed sustained drug release and no significant cytotoxicity differences.

Conclusion: Modified diatoms demonstrated higher drug loading and sustained release, indicating their potential for safe and effective ocular drug delivery. Further studies are recommended to confirm these findings.

改良硅藻基眼悬浮液持续递送双氯芬酸钠:一种新的药物载体方法。
目的:眼科药物由于泪液的快速消除,通常只能持续15分钟左右,只有约2%的吸收,而其余的可能进入鼻黏膜,可能引起全身副作用。硅藻具有结构独特、数量丰富、成本低、耐热、无毒、易获取等特点,是一种很有前景的持续给药解决方案。本研究旨在制备和评价双氯芬酸钠负载在改性硅藻上的眼用悬浮液。方法:用硫酸铝溶液对硅藻进行修饰,然后负载双氯芬酸钠。利用电子显微镜、傅里叶红外光谱、x射线衍射和元素图分析了改性前后硅藻的粒径、表面电荷和载药量等特征。BET (brunauer - emmet - teller,表面积分析)测试提供了吸附数据,而DSC(差示扫描量热法)评估了热性能。体外释放研究使用透析袋在人工泪液检查药物释放超过8小时。采用分光光度法测定药物含量,并观察不同硅藻浓度对MDA-MB-231和HEP-G2细胞株的细胞毒性。结果:改良后的扫描电镜(SEM)未见地形变化。BET和XRD分析证实了药物的负载性和结构稳定性,而FTIR则证实了羧酸基的参与。热重分析(TGA)和差热分析(DSC)显示出稳定的热性能。元素映射证实了表面元素的增加和高药物负荷。修饰硅藻表现出持续的药物释放,没有显著的细胞毒性差异。结论:改性硅藻具有较高的载药量和缓释能力,具有安全有效的眼部给药潜力。建议进一步的研究来证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACYTOXICOLOGY&nb-TOXICOLOGY
CiteScore
4.80
自引率
0.00%
发文量
87
审稿时长
12 weeks
期刊介绍: BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信